To elucidate genes and pathways potentially targeted by GPR160 in prostate cancer cells, differentially expressed genes (DEGs) between scramble- and ShGPR160-treated PC-3 cells were analyzed with Affymetrix GeneChip Human Genome U133 Plus 2.0 Array. This evidence concerns the gene GPR160 and prostate carcinoma.